Skip to search formSkip to main contentSkip to account menu

Polyvalent pneumococcal vaccine

Known as: PPSV, Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient], Pneumococcal Polyvalent Vaccine 
An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains highly purified… 
National Institutes of Health

Related topics

Related topics

12 relations
23-valent pneumococcal capsular polysaccharide vaccineCommunicable DiseasesDrug AllergyHodgkin Disease

Broader (1)

Pneumococcal vaccine

Narrower (1)

Pneumovax 23

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
Predictors of occult pneumococcal bacteremia in young febrile children.
Review
1992
Review
1992
Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae.
Streptococcus pneumoniae is an important agent of disease in man at the extremes of age and in individuals with underlying… 
Highly Cited
1989
Highly Cited
1989
Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components
While there is considerable evidence that both interleukin-1 (IL-1) and tumor necrosis factor (TNF) are central mediators of… 
Highly Cited
1988
Highly Cited
1988
Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal…
Ig class-, and IgA and IgG subclass-specific immune responses to a 23 valent pneumococcal polysaccharide vaccine were studied at… 
Highly Cited
1987
Highly Cited
1987
Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
Apache Indian infants have a high frequency of Haemophilus influenzae type b (Hib) and pneumococcal infections. Forty percent of… 
Highly Cited
1982
Highly Cited
1982
Pneumococcal disease in a medium-sized community in the United States.
To assess the importance of bacteremic pneumococcal disease among the population of one "average" American community, we studied… 
Highly Cited
1977
Highly Cited
1977
Immune function in aged mice. II. B-cell function.
Highly Cited
1972
Highly Cited
1972
Inhibition of secondary anti‐hapten responses with the hapten conjugated to type 3 pneumococcal polysaccharide
An injection of 2, 4‐dinitrophenyl (DNP)‐lysine conjugated to type 3 pneumococcal polysaccharide (DNP‐lysine‐SIII) markedly… 
Highly Cited
1971
Highly Cited
1971
Studies on immunological paralysis: VI. Thymic-independence of tolerance and immunity to type III pneumococcal polysaccharide
Highly Cited
1970
Highly Cited
1970
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.
Mice treated with antilymphocyte serum (ALS) and immunized with type III pneumococcal polysaccharide (SSS-III) showed a tenfold… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)